293 related articles for article (PubMed ID: 10869356)
1. Activation of the pro-drug ethionamide is regulated in mycobacteria.
Baulard AR; Betts JC; Engohang-Ndong J; Quan S; McAdam RA; Brennan PJ; Locht C; Besra GS
J Biol Chem; 2000 Sep; 275(36):28326-31. PubMed ID: 10869356
[TBL] [Abstract][Full Text] [Related]
2. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
[TBL] [Abstract][Full Text] [Related]
3. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
4. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
[TBL] [Abstract][Full Text] [Related]
5. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
[TBL] [Abstract][Full Text] [Related]
6. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
8. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation.
Wang XD; Gu J; Wang T; Bi LJ; Zhang ZP; Cui ZQ; Wei HP; Deng JY; Zhang XE
Mol Microbiol; 2011 Dec; 82(6):1375-91. PubMed ID: 22026918
[TBL] [Abstract][Full Text] [Related]
10. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
[TBL] [Abstract][Full Text] [Related]
11. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.
Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR
Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011
[TBL] [Abstract][Full Text] [Related]
12. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.
Vilchèze C; Weisbrod TR; Chen B; Kremer L; Hazbón MH; Wang F; Alland D; Sacchettini JC; Jacobs WR
Antimicrob Agents Chemother; 2005 Feb; 49(2):708-20. PubMed ID: 15673755
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
[TBL] [Abstract][Full Text] [Related]
14. An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.
Ang ML; Zainul Rahim SZ; Shui G; Dianiškova P; Madacki J; Lin W; Koh VH; Martinez Gomez JM; Sudarkodi S; Bendt A; Wenk M; Mikušová K; Korduláková J; Pethe K; Alonso S
Infect Immun; 2014 May; 82(5):1850-9. PubMed ID: 24566628
[TBL] [Abstract][Full Text] [Related]
15. Mutation in Eth A protein of Mycobacterium tuberculosis conferred drug tolerance against enthinoamide in Mycobacterium smegmatis mc
Anand PK; Kumar A; Saini A; Kaur J
Comput Biol Chem; 2022 Jun; 98():107677. PubMed ID: 35397466
[TBL] [Abstract][Full Text] [Related]
16. A review of the use of ethionamide and prothionamide in childhood tuberculosis.
Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2016 Mar; 97():126-36. PubMed ID: 26586647
[TBL] [Abstract][Full Text] [Related]
17. Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide.
Zhang HN; Xu ZW; Jiang HW; Wu FL; He X; Liu Y; Guo SJ; Li Y; Bi LJ; Deng JY; Zhang XE; Tao SC
Sci Rep; 2017 Jul; 7(1):5860. PubMed ID: 28725053
[TBL] [Abstract][Full Text] [Related]
18. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
19. Mycolic acid synthesis: a target for ethionamide in mycobacteria?
Quémard A; Lanéelle G; Lacave C
Antimicrob Agents Chemother; 1992 Jun; 36(6):1316-21. PubMed ID: 1416831
[TBL] [Abstract][Full Text] [Related]
20. Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in
Cao B; Mijiti X; Deng LL; Wang Q; Yu JJ; Anwaierjiang A; Qian C; Li M; Fang DA; Jiang Y; Zhao LL; Zhao X; Wan K; Liu H; Li G; Yuan X
Infect Drug Resist; 2023; 16():3117-3135. PubMed ID: 37228658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]